343 related articles for article (PubMed ID: 1855215)
1. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.
Watson PH; Pon RT; Shiu RP
Cancer Res; 1991 Aug; 51(15):3996-4000. PubMed ID: 1855215
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the proliferative effect of transforming growth factor-alpha by c-myc antisense DNA in human ovarian cancer cells.
Park HY
Biochem Mol Biol Int; 1997 Dec; 43(5):1015-22. PubMed ID: 9415810
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cell adhesion to plastic substratum by phosphorothioate oligonucleotide.
Watson PH; Pon RT; Shiu RP
Exp Cell Res; 1992 Oct; 202(2):391-7. PubMed ID: 1397092
[TBL] [Abstract][Full Text] [Related]
6. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
Chavany C; Connell Y; Neckers L
Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
[TBL] [Abstract][Full Text] [Related]
7. Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition.
Saijo Y; Uchiyama B; Abe T; Satoh K; Nukiwa T
Jpn J Cancer Res; 1997 Jan; 88(1):26-33. PubMed ID: 9045892
[TBL] [Abstract][Full Text] [Related]
8. Myc protein is differentially sensitive to quinidine in tumor versus immortalized breast epithelial cell lines.
Melkoumian ZK; Martirosyan AR; Strobl JS
Int J Cancer; 2002 Nov; 102(1):60-9. PubMed ID: 12353235
[TBL] [Abstract][Full Text] [Related]
9. A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer.
Akie K; Dosaka-Akita H; Murakami A; Kawakami Y
Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):243-9. PubMed ID: 10984118
[TBL] [Abstract][Full Text] [Related]
10. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells.
Kang Y; Cortina R; Perry RR
J Natl Cancer Inst; 1996 Mar; 88(5):279-84. PubMed ID: 8614006
[TBL] [Abstract][Full Text] [Related]
11. Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells.
Yu BW; Nguyen D; Anderson S; Allegra CA
Anticancer Res; 1997; 17(6D):4407-13. PubMed ID: 9494542
[TBL] [Abstract][Full Text] [Related]
12. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines.
Li BD; Budnick RM; Russo CA; Anderson GR; Stewart CC
J Surg Res; 1995 Oct; 59(4):485-92. PubMed ID: 7564322
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
14. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma.
Williams SA; Gillan ER; Knoppel E; Buzby JS; Suen Y; Cairo MS
Ann Oncol; 1997; 8 Suppl 1():25-30. PubMed ID: 9187425
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.
Spänkuch-Schmitt B; Wolf G; Solbach C; Loibl S; Knecht R; Stegmüller M; von Minckwitz G; Kaufmann M; Strebhardt K
Oncogene; 2002 May; 21(20):3162-71. PubMed ID: 12082631
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effects of a c-myc antisense oligonucleotide on human arterial smooth muscle cells.
Ebbecke M; Unterberg C; Buchwald A; Stöhr S; Wiegand V
Basic Res Cardiol; 1992; 87(6):585-91. PubMed ID: 1485890
[TBL] [Abstract][Full Text] [Related]
17. c-Myc overexpression and endocrine resistance in breast cancer.
McNeil CM; Sergio CM; Anderson LR; Inman CK; Eggleton SA; Murphy NC; Millar EK; Crea P; Kench JG; Alles MC; Gardiner-Garden M; Ormandy CJ; Butt AJ; Henshall SM; Musgrove EA; Sutherland RL
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):147-55. PubMed ID: 17052904
[TBL] [Abstract][Full Text] [Related]
18. Effects of tamoxifen and retinoic acid on cell growth and c-myc gene expression in human breast and cervical cancer cells.
Tsai LC; Hung MW; Yuan CC; Chao PL; Jiang SY; Chang GG; Chang TC
Anticancer Res; 1997; 17(6D):4557-62. PubMed ID: 9494568
[TBL] [Abstract][Full Text] [Related]
19. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
Gryaznov S; Skorski T; Cucco C; Nieborowska-Skorska M; Chiu CY; Lloyd D; Chen JK; Koziolkiewicz M; Calabretta B
Nucleic Acids Res; 1996 Apr; 24(8):1508-14. PubMed ID: 8628685
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotides specific for the HER2/neu oncogene inhibit the growth of human breast carcinoma cells that overexpress HER2/neu.
Roh H; Pippin J; Boswell C; Drebin JA
J Surg Res; 1998 Jun; 77(1):85-90. PubMed ID: 9698539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
